A new variant database for mismatch repair genes associated with lynch syndrome

Human Mutation

Volumn 28, Issue 7, 2007, Pages 669-673

  Woods, Michael O ^a,c   Williams, Phillip ^a   Careen, Amanda ^a   Edwards, Laura ^a   Bartlett, Sylvia ^a   McLaughlin, John R ^b   Younghusband, H Banfield ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

HNPCC; Lynch syndrome; Mismatch repair; MLH1; MMR; MSH2; MSH6; Mutation database; PMS2

Indexed keywords

DNA; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

AUTOSOMAL DOMINANT DISORDER; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; COMPUTER PROGRAM; DISEASE ASSOCIATION; FAMILIAL CANCER; GENE; GENE MUTATION; GENETIC DATABASE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTERNET; MISMATCH REPAIR; MLH1 GENE; MSH2 GENE; MSH6 GENE; PATHOGENICITY; PMS2 GENE; POINT MUTATION; PRIORITY JOURNAL; REVIEW;

BASE PAIR MISMATCH; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DATABASES, GENETIC; HUMANS; MUTATION;

EID: 34447264031     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20502     Document Type: Review

References (29)

1. Aaltonen LA. 1998. Molecular epidemiology of hereditary nonpolyposis colorectal cancer in Finland. Recent Results Cancer Res 154:306-311.
2. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. 1995. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430-433.
3. Auclair J, Busine MP, Navarro C, Ruano E, Montmain G, Desseigne F, Saurin JC, Lasset C, Bonadona V, Giraud S, Puisieux A, Wang Q. 2006. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 27:145-154.
4. Cartegni L, Chew SL, Krainer AR. 2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285-298.
5. Chadwick RB, Meek JE, Prior TW, Peltomaki P, de La Chapelle A. 2000. Polymorphisms in a pseudogene highly homologous to PMS2. Hum Mutat 16:530.
6. Desai DC, Lockman JC, Chadwick RB, Gao X, Percesepe A, Evans DG, Miyaki M, Yuen ST, Radice P, Maher ER, Wright FA, de La Chapelle A. 2000. Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet 37:646-652.
7. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. 1993. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038.
8. Froggatt NJ, Joyce JA, Davies R, Gareth D, Evans R, Ponder BA, Barton DE, Maher ER. 1995. A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome. Lancet 345:727.
9. Froggatt NJ, Green J, Brassett C, Evans DG, Bishop DT, Kolodner R, Maher ER. 1999. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. J Med Genet 36: 97-102.
10. Green J, O'Driscoll M, Barnes A, Maher ER, Bridge P, Shields K, Parfrey PS. 2002. Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation. Dis Colon Rectum 45:1223-1232.
11. Green RC, Green JS, Buehler SK, Robb JD, Daftary D, Gallinger S, McLaughlin JR, Parfrey PS, Younghusband HB. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer (in press) [Epub ahead of print.]
12. Kovtun IV, McMurray CT. 2001. Trinucleotide expansion in haploid germ cells by gap repair. Nat Genet 27:407-411.
13. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan XY, Zhang J, Kao FT, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Jarvinen H, Peterson GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, del a Chapelle A, Kinzler KW, Vogelstein B. 1993. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225.
14. Li L, McVety S, Younan R, Liang P, Du Sart D, Gordon PH, Hutter P, Hogervorst FB, Chong G, Foulkes WD. 2006. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC). Hum Mutat 27:388.
15. Martin A, Li Z, Lin DP, Bardwell PD, Iglesias-Ussel MD, Edelmann W, Scharff MD. 2003. Msh2 ATPase activity is essential for somatic hypermutation at a-T basepairs and for efficient class switch recombination. J Exp Med 198:1171-1178.
16. Martomo SA, Yang WW, Gearhart PJ. 2004. A role for Msh6 but not Msh3 in somatic hypermutation and class switch recombination. J Exp Med 200:61-68.
17. Mitchell RJ, Farrington SM, Dunlop MG, Campbell H. 2002. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 156:885-902.
18. Miyaki M, Konishi M, Muraoka M, Kikuchi-Yanoshita R, Tanaka K, Iwama T, Mori T, Koike M, Ushio K, Chiba M, Nomizu S, Utsunomiya J. 1995. Germ line mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients. J Mol Med 73:515-520.
19. Nystrom-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, Jarvinen HJ, Mecklin JP, Kinzler KW, Vogelstein B, de la Chapelle A, Peltomaki P. 1995. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1:1203-1206.
20. Peltomaki P, Gao X, Mecklin JP. 2001. Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations. Fam Cancer 1:9-15.
21. Peltomaki P, Vasen H. 2004. Mutations associated with HNPCC predisposition - update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20:269-276.
22. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. 1997. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758-1762.
23. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML. 2001. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121:830-838.
24. Savouret C, Brisson E, Essers J, Kanaar R, Pastink A, te Riele H, Junien C, Gourdon G. 2003. CTG repeat instability and size variation timing in DNA repair-deficient mice. EMBO J 22:2264-2273.
25. Stuckless S, Parfrey PS, Woods MO, Cox J, Fitzgerald GW, Green JS, Green RC. The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome. Fam Cancer (in press) [Epub ahead of print.]
26. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton S, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HFA, Hawk ET, Barrett JC, Freedman AN, Srivastava S. 2004. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268.
27. Vasen HF, Mecklin JP, Khan PM, Lynch HT. 1991. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424-425.
28. Vasen HF, Watson P, Mecklin JP, Lynch HT. 1999. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456.
29. Warthin AS. 1913. Heredity with reference to carcinoma. Arch Intern Med 12:546-555.